Cui Xinye, Tang Yuqiang, Guan Guoxin, Zhang Zhongtao, Luo Fuwen
Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Department of General Surgery, The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning, China.
Am J Case Rep. 2025 Apr 7;26:e947094. doi: 10.12659/AJCR.947094.
BACKGROUND Women are at an increased risk of developing venous thrombosis during gestation and the postpartum period, due to physiological and anatomical changes. Superior mesenteric vein thrombosis (SMVT) is a rare and severe complication with a dangerous course and a high mortality rate. Heparin-induced thrombocytopenia (HIT) is also rare in patients treated with heparin and presents with thrombosis and thrombocytopenia. We report a patient with SMVT diagnosis who was treated with heparin anticoagulation after surgery and eventually developed HIT. CASE REPORT The patient was a 30-year-old woman with a diagnosis of SMVT 10 days after giving birth to her second child. She was treated with heparin anticoagulation and interventional catheter-based thrombolysis and thrombectomy, which was ineffective, and she showed peritonitis. We therefore performed an emergency laparotomy, during which we found partial small intestine necrosis and performed a partial small bowel resection. However, the systemic thrombosis worsened postoperatively, and after a multidisciplinary team consultation, HIT was diagnosed. After switching to non-heparin anticoagulation, the patient's condition improved, and she was discharged from the hospital. CONCLUSIONS This is the first case report of HIT secondary to heparin anticoagulation in a parturient who underwent surgery for intestinal necrosis caused by SMVT. Our case highlights the challenge of treating SMVT and the difficulty of diagnosis of HIT. SMVT is a serious condition that requires sufficient experience to judge the timing of surgery. HIT is a rare complication that occurs during heparin use, and its timely diagnosis and treatment have a significant impact on patient prognosis.
由于生理和解剖学变化,女性在妊娠期和产后发生静脉血栓形成的风险增加。肠系膜上静脉血栓形成(SMVT)是一种罕见且严重的并发症,病程凶险,死亡率高。肝素诱导的血小板减少症(HIT)在接受肝素治疗的患者中也很罕见,表现为血栓形成和血小板减少。我们报告一例诊断为SMVT的患者,术后接受肝素抗凝治疗,最终发生了HIT。病例报告:该患者为一名30岁女性,在生下第二个孩子10天后被诊断为SMVT。她接受了肝素抗凝以及基于介入导管的溶栓和血栓切除术,但治疗无效,且出现了腹膜炎。因此,我们进行了急诊剖腹手术,术中发现部分小肠坏死并进行了部分小肠切除术。然而,术后全身血栓形成恶化,经过多学科团队会诊,诊断为HIT。改用非肝素抗凝后,患者病情好转并出院。结论:这是首例关于因SMVT导致肠坏死而接受手术的产妇在肝素抗凝后发生HIT的病例报告。我们的病例突出了治疗SMVT的挑战以及HIT诊断的困难。SMVT是一种严重疾病,需要足够的经验来判断手术时机。HIT是肝素使用过程中发生的罕见并发症,其及时诊断和治疗对患者预后有重大影响。